Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis
TORONTO, ON / ACCESSWIRE / September 9, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces that through its subsidiary, HUGE Biopharma Australia Pty Ltd.
Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements
TORONTO, ON / ACCESSWIRE / September 6, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that it has received a formal notice from The Nasdaq Stock Market, LLC ("Nasdaq") stating that the Company has regained compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the Nasdaq Listing Rules.
Quantum Biopharma Announces Celly Nutrition Launches unbuzzd(TM) Grab-and-Go Stick Packs on Amazon.com so you can "own NOW and what's NEXT"
TORONTO, ON / ACCESSWIRE / August 30, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces that highly-anticipated launch of unbuzzd™, a groundbreaking product designed to help individuals recover from the adverse effects of alcohol consumption and prepare for what's next.
Quantum Increases its Per Share Price With Reverse Stock Split
To raise its share price and ensure compliance with Nasdaq's listing requirements, QMCO implements a 1-for-20 reverse stock split.
Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update
TORONTO, ON / ACCESSWIRE / August 23, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce the following corporate updates.
Quantum (QMCO) Q1 Loss Wider Than Expected, Sales Fall Y/Y
Quantum's (QMCO) Q1 fiscal 2025 performance is affected by weakness across Product, Service and subscription and Royalty business segments.
Quantum Corporation (QMCO) Q1 2025 Earnings Call Transcript
Quantum Corporation (NASDAQ:QMCO ) Q1 2025 Earnings Conference Call August 13, 2024 5:00 PM ET Company Participants Brian Cabrera – Chief Administrative Officer Jamie Lerner – Chairman and Chief Executive Officer Ken Gianella – Chief Financial Officer Conference Call Participants Neal Chokshi – Northland Capital Markets Max Michaelis – Lake Street Capital Markets Operator Greetings, welcome to Quantum Corporation's First Quarter Fiscal Year 2025 Financial Results. At this time all participants are in a listen-only mode.
What Are the Hottest Quantum Computing Stocks Right Now? 3 Top Picks.
Quantum computers are a big deal because they can process billions of simple logic operations per second, light-years ahead of classical machines and computers. Regular computers use binary switches (ones and zeros) for their calculations.
3 Quantum Computing Stocks with Long-Term Growth Potential
Imagine if years ago you got into quantum computing stocks and made loads of money from companies that are heavily invested in AI and quantum technology. You'd be sitting pretty!
Spectral Capital Corporation (FCCN), Led by Sean Michael Brehm, Launches Quantum Bridge Program to Advance Quantum Computing Innovations
NEW YORK, NY / ACCESSWIRE / August 5, 2024 / Spectral Capital Corporation (OTCQB:FCCN), under the leadership of Chairman and Board Director Sean Michael Brehm, is excited to announce the launch of its innovative Quantum Bridge Program. This groundbreaking initiative is designed to fast-track the development and commercialization of quantum computing technologies, bridging the gap between cutting-edge research and practical applications.
Get Your Money Out of These 3 Quantum Computing Stocks by 2025
Quantum mechanics could very well unlock the next stage of modern computing. Scientists can leverage the complex physics of subatomic particles to develop advanced computing systems.
3 Quantum Computing Stocks to Bet on for Market-Crushing Returns
Quantum computing holds massive potential, creating substantial opportunities for quantum computing stocks. For example, a recent McKinsey report states that quantum computing could help generate nearly $2 trillion in value for chemicals, life sciences, finance, and mobility by 2035.
